{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:27:10Z","timestamp":1791466030900,"version":"4.3.4"},"reference-count":33,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CIBER of Diabetes and Associated Metabolic Diseases","award":["PI17\/0497"],"award-info":[{"award-number":["PI17\/0497"]}]},{"name":"CIBER of Diabetes and Associated Metabolic Diseases","award":["PI21\/00506"],"award-info":[{"award-number":["PI21\/00506"]}]},{"name":"CIBER of Diabetes and Associated Metabolic Diseases","award":["AP11-091"],"award-info":[{"award-number":["AP11-091"]}]},{"name":"CIBER of Diabetes and Associated Metabolic Diseases","award":["PID2019-108977RB-I00"],"award-info":[{"award-number":["PID2019-108977RB-I00"]}]},{"name":"FIS","award":["PI17\/0497"],"award-info":[{"award-number":["PI17\/0497"]}]},{"name":"FIS","award":["PI21\/00506"],"award-info":[{"award-number":["PI21\/00506"]}]},{"name":"FIS","award":["AP11-091"],"award-info":[{"award-number":["AP11-091"]}]},{"name":"FIS","award":["PID2019-108977RB-I00"],"award-info":[{"award-number":["PID2019-108977RB-I00"]}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PI17\/0497"],"award-info":[{"award-number":["PI17\/0497"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PI21\/00506"],"award-info":[{"award-number":["PI21\/00506"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["AP11-091"],"award-info":[{"award-number":["AP11-091"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PID2019-108977RB-I00"],"award-info":[{"award-number":["PID2019-108977RB-I00"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Science and Innovation","award":["PI17\/0497"],"award-info":[{"award-number":["PI17\/0497"]}]},{"name":"Spanish Ministry of Science and Innovation","award":["PI21\/00506"],"award-info":[{"award-number":["PI21\/00506"]}]},{"name":"Spanish Ministry of Science and Innovation","award":["AP11-091"],"award-info":[{"award-number":["AP11-091"]}]},{"name":"Spanish Ministry of Science and Innovation","award":["PID2019-108977RB-I00"],"award-info":[{"award-number":["PID2019-108977RB-I00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Patients with high cholesterol and glucose levels are at high risk for cardiovascular disease. The Sterol Regulatory Element Binding Protein (SREBP) system regulates genes involved in lipid, cholesterol and glucose pathways. Autosomal Dominant Hypercholesterolemias (ADHs) are a group of diseases with increased cholesterol levels. They affect 1 out of every 500 individuals. About 20\u201330% of patients do not present any mutation in the known genes (LDLR, APOB and PCSK9). ADHs constitute a good model to identify the genes involved in the alteration of lipid levels or possible therapeutic targets. In this paper, we studied whether a mutation in the SREBP system could be responsible for ADH and other metabolic alterations present in these patients. Forty-one ADH patients without mutations in the main responsible genes were screened by direct sequencing of SREBP system genes. A luciferase reporter assay of the found mutation and an oral glucose tolerance test in carriers and non-carriers were performed. We found a novel mutation in the SREBF2 gene that increases transcription levels and cosegregates with hypercholesterolemia, and we found increased glucose levels in one family. SREBP2 is known to be involved in cholesterol synthesis, plasma levels and glucose metabolism in humans. The found mutation may involve the SREBF2 gene in hypercholesterolemia combined with hyperglycemia.<\/jats:p>","DOI":"10.3390\/biomedicines10051178","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T12:25:57Z","timestamp":1652963157000},"page":"1178","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Very Rare Variant in SREBF2, a Possible Cause of Hypercholesterolemia and Increased Glycemic Levels"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-6606","authenticated-orcid":false,"given":"Ana-B\u00e1rbara","family":"Garc\u00eda-Garc\u00eda","sequence":"first","affiliation":[{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain"},{"name":"Genomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-2034","authenticated-orcid":false,"given":"Sergio","family":"Mart\u00ednez-Herv\u00e1s","sequence":"additional","affiliation":[{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain"},{"name":"Department of Medicine, University of Valencia, 46010 Valencia, Spain"},{"name":"Endocrinology Service, University Clinical Hospital of Valencia, 46010 Valencia, Spain"},{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Vernia","sequence":"additional","affiliation":[{"name":"Biomedical Institute of Valencia (IBV-CSIC), 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ivorra","sequence":"additional","affiliation":[{"name":"Genomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1637-6702","authenticated-orcid":false,"given":"In\u00e9s","family":"Pulido","sequence":"additional","affiliation":[{"name":"University of Illinois Hospital & Health Sciences System Cancer Center, University of Illinois Chicago, Chicago, IL 60612, USA"},{"name":"Department of Physiology, University of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Mart\u00edn-Escudero","sequence":"additional","affiliation":[{"name":"Internal Medicine Service, Rio Hortega Hospital, 47012 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-4650","authenticated-orcid":false,"given":"Marta","family":"Casado","sequence":"additional","affiliation":[{"name":"Biomedical Institute of Valencia (IBV-CSIC), 46010 Valencia, Spain"},{"name":"CIBER of Hepatic and Digestive Diseases (CIBEREHD), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Carretero","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 T.","family":"Real","sequence":"additional","affiliation":[{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain"},{"name":"Department of Medicine, University of Valencia, 46010 Valencia, Spain"},{"name":"Endocrinology Service, University Clinical Hospital of Valencia, 46010 Valencia, Spain"},{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-3689","authenticated-orcid":false,"given":"Felipe Javier","family":"Chaves","sequence":"additional","affiliation":[{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain"},{"name":"Genomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Euro Heart Survey Investigators, Bartnik, M., Ryd\u00e9n, L., Ferrari, R., Malmberg, K., Py\u00f6r\u00e4l\u00e4, K., Simoons, M., Standl, E., Soler-Soler, J., and Ohrvik, J. (2004). The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart. Eur. Heart J., 25, 1880\u20131890.","DOI":"10.1016\/j.ehj.2004.07.027"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"14","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"2007","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: Master regulators of lipid homeostasis","volume":"86","author":"Hegarty","year":"2004","journal-title":"Biochimie"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ceb.2007.02.004","article-title":"SREBP in signal transduction: Cholesterol metabolism and beyond","volume":"19","author":"Ericsson","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1194\/jlr.M064022","article-title":"SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression","volume":"57","author":"Vergnes","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: Convergent physiology\u2014Divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jmg.39.4.271","article-title":"Identification of mutations in the gene encoding sterol regulatory element binding protein (SREBP)-2 in hypercholesterolaemic subjects","volume":"39","author":"Muller","year":"2002","journal-title":"J. Med. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/db12-0858","article-title":"Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism","volume":"62","author":"Musso","year":"2013","journal-title":"Diabetes"},{"key":"ref_10","unstructured":"Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (2001). Familial Hypercholesterolemia. The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2007.00915.x","article-title":"Genetic heterogeneity of autosomal dominant hypercholesterolemia","volume":"73","author":"Varret","year":"2008","journal-title":"Clin. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial Hypercholesterolemia. Epidemiology, Diagnosis, and Screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/gm13","article-title":"The Human Gene Mutation Database: 2008 update","volume":"22","author":"Stenson","year":"2009","journal-title":"Genome Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1573403X15666191111123622","article-title":"Assessing Cardiovascular Risk in Patients with Diabetes: An Update","volume":"16","author":"Damaskos","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0025-7753(01)72209-9","article-title":"Risk factors associated to hospitalization in diabetic patients with foot ulcers","volume":"117","author":"Real","year":"2001","journal-title":"Med. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0003-2697(89)90163-2","article-title":"Use of silica gel polymer for DNA extraction with organic solvents","volume":"183","author":"Tilzer","year":"1989","journal-title":"Anal. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/humu.20355","article-title":"Semiquantitative multiplex PCR: A useful tool for large rearrangement screening and characterization","volume":"27","author":"Blesa","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/clinchem\/hvaa002","article-title":"Easy One-Step Amplification and Labeling Procedure for Copy Number Variation Detection","volume":"66","author":"Blesa","year":"2020","journal-title":"Clin. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.atherosclerosis.2011.07.106","article-title":"Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: Importance of genetic testing in the entire family","volume":"218","author":"Ivorra","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/humu.20256","article-title":"Update of the molecular basis of familial hypercholesterolemia in The Netherlands","volume":"26","author":"Fouchier","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1210\/jc.2008-0269","article-title":"A New PCSK9 Gene Promoter Variant Affects Gene Expression and Causes Autosomal Dominant Hypercholesterolemia","volume":"93","author":"Blesa","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","unstructured":"Krawetz, S., and Misener, S. (2000). Bioinformatics Methods and Protocols: Methods in Molecular Biology, Humana Press."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ma, K., Malhotra, P., Soni, V., Hedroug, O., Annaba, F., Dudeja, A., Shen, L., Turner, J.R., Khramtsova, E.A., and Saksena, S. (2014). Overactivation of Intestinal SREBP2 in Mice Increases Serum Cholesterol. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084221"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0021-9150(01)00762-6","article-title":"Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia","volume":"164","author":"Miserez","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2006.01.001","article-title":"The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients","volume":"189","author":"Durst","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI119746","article-title":"Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene","volume":"100","author":"Shimano","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2007.01.003","article-title":"Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus","volume":"120","author":"Rader","year":"2007","journal-title":"Am. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1194\/jlr.M800238-JLR200","article-title":"Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: A new model for lipotoxicity","volume":"49","author":"Ishikawa","year":"2008","journal-title":"J. Lipid Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:15:05Z","timestamp":1760138105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["biomedicines10051178"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10051178","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}